Tag
Emcure Pharmaceuticals Limited
3 articles
Emcure Subsidiary Acquires 100% of Mantra Pharma Shares
Emcure's subsidiary Marcan Pharmaceuticals acquired 100% of Class E Special Shares in step-down subsidiary Mantra Pharma for CAD $50 million.
The acquisition, executed on July 2, 2026, consolidates Ma
Emcure President API Business Superannuates
Emcure Pharmaceuticals discloses senior management change under SEBI Regulation 30.
President - API Business Kuber Jagdale superannuates effective June 30, 2026.
Cessation does not constitute resignat
Emcure FY26 Revenue Growth 16.6%, Margin Expansion
Emcure Pharmaceuticals reported FY26 revenue of ₹9,204 Cr, a 16.6% YoY growth, exceeding guidance with strong international performance.
EBITDA margin expanded 80 bps to 19.4% and Adj. PAT margin impr